Samsung Biomedical Research Institute, Samsung Advanced Institute of Technology (SAIT), Samsung Electronics Co. Ltd., Seoul 135-710, Korea; Samsung Genome Institute, Samsung Medical Center, Seoul 135-710, Korea.
Department of Biochemistry and Department of Biomedical Sciences, Ajou University School of Medicine, Suwon 443-749, Korea.
Biomaterials. 2014 Aug;35(26):7501-10. doi: 10.1016/j.biomaterials.2014.05.039. Epub 2014 Jun 7.
Circulating tumor cells (CTCs) are rare cells and the presence of these cells may indicate a poor prognosis and a high potential for metastasis. Despite highly promising clinical applications, CTCs have not been investigated thoroughly, due to many technical limitations faced in their isolation and identification. Current CTC detection techniques mostly take the epithelial marker epithelial cell adhesion molecule (EpCAM), however, accumulating evidence suggests that CTCs show heterogeneous EpCAM expression due to the epithelial-to-mesenchymal transition (EMT). In this study, we report that a microchip filter device incorporating slit arrays and 3-dimensional flow that can separate heterogeneous population of cells with marker for CTCs. To select target we cultured breast cancer cells under prolonged mammosphere culture conditions which induced EMT phenotype. Under these conditions, cells show upregulation of caveolin1 (CAV1) but down-regulation of EpCAM expression. The proposed device which contains CAV1-EpCAM conjugated bead has several tens of times increased throughput. More importantly, this platform enables the enhanced capture yield from metastatic breast cancer patients and obtained cells that expressed various EMT markers. Further understanding of these EMT-related phenotypes will lead to improved detection techniques and may provide an opportunity to develop therapeutic strategies for effective treatment and prevention of cancer metastasis.
循环肿瘤细胞 (CTCs) 是罕见的细胞,这些细胞的存在可能表明预后不良,转移的可能性很高。尽管具有非常有前途的临床应用,但由于在其分离和鉴定方面面临许多技术限制,CTC 尚未得到充分研究。目前的 CTC 检测技术大多采用上皮标志物上皮细胞黏附分子 (EpCAM),然而,越来越多的证据表明,由于上皮-间充质转化 (EMT),CTC 表现出异质性 EpCAM 表达。在这项研究中,我们报告了一种微芯片过滤装置,该装置结合了狭缝阵列和 3 维流动,可以分离具有 CTC 标志物的异质细胞群。为了选择靶标,我们在延长的乳腺球体培养条件下培养乳腺癌细胞,诱导 EMT 表型。在这些条件下,细胞显示出 caveolin1 (CAV1) 的上调和 EpCAM 表达的下调。包含 CAV1-EpCAM 缀合珠的提议装置的吞吐量增加了几十倍。更重要的是,该平台能够从转移性乳腺癌患者中增强捕获产量,并获得表达各种 EMT 标志物的细胞。进一步了解这些 EMT 相关表型将导致改进的检测技术,并可能为有效治疗和预防癌症转移提供开发治疗策略的机会。